{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:45:57Z","timestamp":1767134757238,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":151,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003443.pub2","type":"reference-entry","created":{"date-parts":[[2005,1,20]],"date-time":"2005-01-20T13:33:34Z","timestamp":1106228014000},"source":"Crossref","is-referenced-by-count":13,"title":["Perphenazine for schizophrenia"],"prefix":"10.1002","author":[{"given":"Benno","family":"Hartung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Laux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,1,24]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD003443.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.14789\/pjmj.19.239","article-title":"The comparison of therapeutic effects of FK-880 (sulpiride) and perphenazine in schizophrenia by a double-blind controlled study","volume":"19","author":"Amakusa","year":"1973","journal-title":"Juntendo Igako"},{"key":"10.1002\/14651858.CD003443.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archpsyc.1961.01710100093011","article-title":"Five Phenothiazine Derivates. Evaluation and Toxicity Studies","volume":"4","author":"Bennett","year":"1961","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/archpsyc.1975.01760280093009","article-title":"Amitriptyline-perphenazine interaction in ambulatory schizophrenic patients. A controlled study of drug interaction","volume":"32","author":"Chouinard","year":"1975","journal-title":"Archives of General Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD003443.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/archpsyc.1977.01770200089011","article-title":"Phenothiazine-induced ECG abnormalities. Effect of a glucose load","volume":"34","author":"Chouinard","year":"1977","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1192\/bjp.113.505.1425","article-title":"A double-blind trial of amitriptyline-perphenazine, perphenazine and placebo in chronic withdrawn inert schizophrenics","volume":"113","author":"Collins","year":"1967","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB6|cit6","unstructured":"Eckmann F Weber J No English version available unpublished manuscript 1984"},{"issue":"8","key":"10.1002\/14651858.CD003443.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1185\/03007997809110194","article-title":"Loxapine versus perphenazine in psychotic patients. A double-blind, randomized, multicentre trial","volume":"5","author":"Fruensgaard","year":"1978","journal-title":"Current Medical Research and Opinion"},{"issue":"8","key":"10.1002\/14651858.CD003443.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1185\/03007997809110194","article-title":"Loxapine versus perphenazine in psychotic patients. A double-blind, randomized, multicentre trial","volume":"5","author":"Fruensgaard","year":"1978","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD003443.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/j.1552-4604.1964.tb00103.x","article-title":"The comparative effectiveness of amitriptyline, perphenazine, and their combination in the treatment of chronic psychotic female patients","volume":"4","author":"Hanlon","year":"1964","journal-title":"The Journal of New Drugs"},{"issue":"2","key":"10.1002\/14651858.CD003443.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00403632","article-title":"The comparative effectiveness of eight phenothiazines","volume":"7","author":"Hanlon","year":"1965","journal-title":"Psychopharmacologia"},{"issue":"6","key":"10.1002\/14651858.CD003443.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0447.1993.tb03480.x","article-title":"Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations","volume":"88","author":"Hoyberg","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD003443.pub2-BIB12|cit12","first-page":"285","article-title":"Comparison of efficacy of zotepine and perphenazine in schizophrenia by double-blind, controlled study","volume":"2","author":"Imai","year":"1980","journal-title":"Shinkei Seishin Yakuri"},{"issue":"6","key":"10.1002\/14651858.CD003443.pub2-BIB13|cit13","first-page":"465","article-title":"A comparison between the clinical effectiveness of a dibenzothiazepine derivative and a phenothiazine derivative in schizophrenia. A controlled double blind study using clotiapine (W 130) and perphenazine","volume":"11","author":"Itoh","year":"1969","journal-title":"Seishin Igaku"},{"issue":"4","key":"10.1002\/14651858.CD003443.pub2-BIB14|cit14","first-page":"284","article-title":"Comparison of thiothixene and perphenazine in schizophrenic patients using double-blind technique","volume":"11","author":"Itoh","year":"1969","journal-title":"Seishin Igaku"},{"issue":"2","key":"10.1002\/14651858.CD003443.pub2-BIB15|cit15","first-page":"131","article-title":"Comparison of a butyrophenone derivative (methylperidol) and a phenothiazine derivative (perphenazine) in schizophrenic patients using double-blind technique: statistical analysis by sequential method and wilcoxon test","volume":"11","author":"Itoh","year":"1969","journal-title":"Seishin Igaku"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB16|cit16","first-page":"101","article-title":"Comparison of clinical effects of penfluridol, a long-acting oral neuroleptic, and perphenazine in schizophrenia using double-blind technique","volume":"4","author":"Itoh","year":"1976","journal-title":"Rinsho Hyoka"},{"issue":"4","key":"10.1002\/14651858.CD003443.pub2-BIB17|cit17","first-page":"519","article-title":"Clinical evaluation of clocapramine (clofekton) in schizophrenia: a double blind comparison of clocapramine, haloperidol and perphenazine","volume":"12","author":"Kurihara","year":"1983","journal-title":"Rinsho Seishin Igaku"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005053-196107000-00001","article-title":"The comparative effectiveness of six phenothiazine compounds, phenobarbital and inert placebo in the treatment of acutely ill patients: global measures of severity of illness","volume":"133","author":"Kurland","year":"1961","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD003443.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00005053-196101000-00010","article-title":"Comparative studies of the phenothiazine tranquilizers: methodological and logistical considerations","volume":"132","author":"Kurland","year":"1961","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1600-0447.1989.tb01305.x","article-title":"Sulpiride and perphenazine in schizophrenia. A double-blind clinical trial","volume":"80","author":"Lepola","year":"1989","journal-title":"Acta Psychatrica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD003443.pub2-BIB21|cit21","first-page":"404","article-title":"Clinical comparison of methophenazine and perphenazine in schizophrenia. A controlled study. Effects on the photomyoclonic threshold","volume":"9","author":"Nahunek","year":"1967","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD003443.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1192\/bjp.129.6.547","article-title":"Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity","volume":"129","author":"Praag van","year":"1976","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2007-1017093","article-title":"Zuclopenthixol and perphenazine in patients with acute psychotic states. A double-blind multicentre study","volume":"20","author":"Remvig","year":"1987","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003443.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/030006058201000412","article-title":"Comparison of efficacy of a new butyrophenone derivative, timiperone and perphenazine in schizophrenia by a multicentre controlled study","volume":"10","author":"Takahashi","year":"1982","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD003443.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1192\/bjp.109.460.422","article-title":"Withdrawal of perphenazine in chronic schizophrenia","volume":"109","author":"Whittaker","year":"1963","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB27|cit26","first-page":"155","article-title":"Effects and side-effects of bromperidol in comparison with other antipsychotic drugs","volume":"78","author":"Woggon","year":"1978","journal-title":"Acta Psychiatrica Belgica"},{"key":"10.1002\/14651858.CD003443.pub2-BIB26|cit27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000468337","article-title":"Double-blind comparison of bromperidol and perphenazine","volume":"13","author":"Woggon","year":"1978","journal-title":"International Pharmacopsychiatry"},{"issue":"519","key":"10.1002\/14651858.CD003443.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1192\/bjp.115.519.173","article-title":"Penicillamine and schizophrenia - a clinical trial","volume":"115","author":"Affleck","year":"1969","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0447.1980.tb07085.x","article-title":"Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial","volume":"279","author":"Ahlfors","year":"1980","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"2","key":"10.1002\/14651858.CD003443.pub2-BIB30|cit30","first-page":"267","article-title":"Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazine decanoate, flusipirilene, penfluridol, perphenazine enanthate and pipothiazine palmitate","volume":"25","author":"Angst","year":"1975","journal-title":"Arzneimittel Forschung"},{"key":"10.1002\/14651858.CD003443.pub2-BIB31|cit31","unstructured":"Anonymous Schizophrenic and other psychotic reactions Medical Letter 1966 15 6"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB32|cit32","first-page":"73","article-title":"Study of the clinical effects of sulpiride and perphenazine in 82 schizophrenic patients by the double-blind method","volume":"2","author":"Asada","year":"1976","journal-title":"Encephale"},{"key":"10.1002\/14651858.CD003443.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0447.1973.tb08446.x","article-title":"Clinical experience with depot neuroleptics","volume":"246","author":"Bakke","year":"1973","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"6","key":"10.1002\/14651858.CD003443.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1176\/ajp.127.6.827","article-title":"Evaluation of an amitriptyline-perphenazine combination in chronic schizophrenia","volume":"127","author":"Becker","year":"1970","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.0954-6820.1965.tb01883.x","article-title":"Perphenazine (trilafon) in the prophylaxis of nausea and vomiting following acute myocardial infarct","volume":"177","author":"Bjerkelund","year":"1965","journal-title":"Acta Medica Scandinavica"},{"key":"10.1002\/14651858.CD003443.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1099-1077(200004)15:3<179::AID-HUP156>3.0.CO;2-N","article-title":"Ritanserin as add-on medication to neuroleptic therapy for patients with chronic or subchronic schizophrenia","volume":"15","author":"Boer den","year":"2000","journal-title":"Human Psychopharmacology"},{"issue":"47","key":"10.1002\/14651858.CD003443.pub2-BIB37|cit37","first-page":"5445","article-title":"No English title available","volume":"35","author":"B\u00f6hlau","year":"1985","journal-title":"Therapiewoche"},{"issue":"3","key":"10.1002\/14651858.CD003443.pub2-BIB38|cit38","first-page":"337","article-title":"Perphenazine in obstetrics. Evaluation of its use to replace an analgesic","volume":"14","author":"Cannistra","year":"1959","journal-title":"Obstetrics and Gynecology"},{"issue":"3-4","key":"10.1002\/14651858.CD003443.pub2-BIB39|cit39","first-page":"151","article-title":"Risperidone vs. perphenazine - a double-blind comparison and prolactine plasma levels","volume":"6","author":"Ceskova","year":"1994","journal-title":"Psychiatria Danubina"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB40|cit40","first-page":"50","article-title":"Efficacy and tolerability of risperidone in different dose levels","volume":"92","author":"Ceskova","year":"1996","journal-title":"Ceskoslovenska Psychiatrie"},{"key":"10.1002\/14651858.CD003443.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2044.1981.tb08728.x","article-title":"Amitriptyline and perphenazine (triptafen DA) in chronic pain","volume":"36","author":"Clarke","year":"1981","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD003443.pub2-BIB42|cit42","doi-asserted-by":"crossref","unstructured":"Cohen H Trilafon in the treatment of chronically psychotic hospitalized patients Pr\u00fcfbericht, New York. E. Merck Darmstadt 1958","DOI":"10.1176\/ajp.115.5.452"},{"key":"10.1002\/14651858.CD003443.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0364-7722(79)90048-1","article-title":"Metabolic interaction between amitriptyline and perphenazine in psychiatric patients","volume":"3","author":"Cooper","year":"1979","journal-title":"Neuro-Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF02245440","article-title":"A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients","volume":"114","author":"Dencker","year":"1994","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD003443.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/jps.2600710811","article-title":"Serum prolactin level increase in normal subjects following administration of perphenazine oral dosage forms: possible application to bioavailibility testing","volume":"71","author":"Erb","year":"1982","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"8","key":"10.1002\/14651858.CD003443.pub2-BIB46|cit46","first-page":"534","article-title":"Double-blind comparison of two depot neuroleptics (perphenazine enanthate and flupentixol enanthate) in chronic schizophrenia","volume":"50","author":"Eufe","year":"1979","journal-title":"Nervenarzt"},{"key":"10.1002\/14651858.CD003443.pub2-BIB47|cit47","first-page":"653","article-title":"Treatment of choreic movements with perphenazine","volume":"33","author":"Fahn","year":"1972","journal-title":"Diseases of The Nervous System"},{"issue":"8","key":"10.1002\/14651858.CD003443.pub2-BIB48|cit48","first-page":"515","article-title":"A double-blind comparison of haloperidol with perphenazine in acute psychiatric patients","volume":"11","author":"Fitzgerald","year":"1969","journal-title":"Current Therapeutic Research"},{"issue":"4","key":"10.1002\/14651858.CD003443.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-0447.1977.tb00170.x","article-title":"Antiparkinsonian agents and long-term neuroleptic treatment. Effect of G31.406, orphenadrine, and placebo on parkinsonism, schizophrenic symptoms, depression and anxiety","volume":"55","author":"Gerlach","year":"1977","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD003443.pub2-BIB50|cit50","first-page":"227","article-title":"Pathophysiological mechanisms and clinical trials","volume":"14","author":"Gerlach","year":"1988","journal-title":"L'Encephale"},{"key":"10.1002\/14651858.CD003443.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/ajp.121.2.179","article-title":"Clinical trial of a potentiated diketopiperazine derivative as a psychopharmacological agent for the treatment of psychotic patients","volume":"121","author":"Gerson","year":"1964","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB52|cit52","first-page":"7","article-title":"No English title available","volume":"25","author":"Gianelli","year":"1990","journal-title":"Rivista di Psichiatria"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB53|cit53","first-page":"60","article-title":"Controlled studies with thiothixene and perphenzine in schizophrenic psychoses","volume":"12","author":"Hadlik","year":"1970","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD003443.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2125.1979.tb00900.x","article-title":"Plasma levels of perphenazine and its metabolites during simultaneous treatment with anticholinergic drugs","volume":"7","author":"Hansen","year":"1979","journal-title":"British Journal of clinical Pharmacology"},{"key":"10.1002\/14651858.CD003443.pub2-BIB55|cit55","first-page":"135","article-title":"Perphenazine (Fentazine) in the management of chronic schizophrenia","volume":"46","author":"Haran","year":"1960","journal-title":"Journal of the Irish Medical Association"},{"issue":"3","key":"10.1002\/14651858.CD003443.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/009127006900900305","article-title":"Comparison of perphenazine and P-5227 in chronic schizophrenics: clinical and EEG effects","volume":"9","author":"Holden","year":"1969","journal-title":"Journal of Clinical Pharmacology and the Journal of New Drugs"},{"key":"10.1002\/14651858.CD003443.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1967.01730280102012","article-title":"Drug therapy of depression","volume":"17","author":"Hollister","year":"1967","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archpsyc.1974.01760070072011","article-title":"Specific indications for different classes of phenothiazines","volume":"30","author":"Hollister","year":"1974","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/archpsyc.1964.01720240093010","article-title":"Perphenazine (trilafon) metabolism in psychotic patients","volume":"10","author":"Huang","year":"1964","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB60|cit60","first-page":"1065","article-title":"Treatment of delirium tremens. A comparative evaluation of four drugs","volume":"33","author":"Kaim","year":"1972","journal-title":"Quart. J. Stud."},{"issue":"8","key":"10.1002\/14651858.CD003443.pub2-BIB61|cit61","first-page":"867","article-title":"Comparison of clinical efficacy of clocapramine and perphenazine for chronic schizophrenia by the double-blind study","volume":"3","author":"Kaji","year":"1974","journal-title":"Rinsyo Seisin Igaku"},{"issue":"9","key":"10.1002\/14651858.CD003443.pub2-BIB62|cit62","first-page":"2440","article-title":"Drug therapy of acute schizophrenia","volume":"20","author":"Kawakita","year":"1965","journal-title":"Saishin Igaku"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF02316862","article-title":"Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Serum levels at the minimum effective dose","volume":"105","author":"Kistrup","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD003443.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0447.1968.tb02029.x","article-title":"A controlled seven year study of endocrine and other indices in drug treated chronic schizophrenics","volume":"206","author":"Kline","year":"1968","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD003443.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0447.1985.tb08537.x","article-title":"Perphenazine decanoate vs. perphenazine enanthate - efficacy and side-effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients","volume":"322","author":"Knudsen","year":"1985","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD003443.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1176\/ajp.117.4.358","article-title":"A comparison of perphenazine, proketazine, nialamide and MO-482 in chronic schizophrenics","volume":"117","author":"Kothari","year":"1960","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB67|cit67","series-title":"International Journal of Neuropsychiatry","first-page":"403","article-title":"A double-blind evaluation of chlorpromazine versus a combination of perphenazine and amitriptyline","author":"Lapolla","year":"1967"},{"key":"10.1002\/14651858.CD003443.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0920-9964(97)00034-0","article-title":"Immediate effects of chlorpromazine and perphenazine following neuroleptic washout on word association of schizophrenic patients","volume":"26","author":"Levine","year":"1997","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00426949","article-title":"Effects of perphenazine injections on prolactin levels in plasma from schizophrenic women and men","volume":"57","author":"Lindholm","year":"1978","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD003443.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1176\/ajp.139.10.1329","article-title":"Interaction between antidepressants and perphenazine in psychiatric inpatients","volume":"139","author":"Linnoila","year":"1982","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD003443.pub2-BIB71|cit71","first-page":"497","article-title":"Sleep in psychotic patients: a comparative clinical study","volume":"3","author":"Loprete","year":"1967","journal-title":"International journal of neuropsychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB73|cit72","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/ajp.114.2.173-a","article-title":"Perphenazine - a drug modifying consciousness","volume":"114","author":"Mason-Browne","year":"1957","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB72|cit73","first-page":"300","article-title":"Effect of perphenazine (trilafon) on modification of crude consciousness","volume":"18","author":"Mason-Browne","year":"1957","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD003443.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00000542-195801000-00012","article-title":"Control of postoperative vomiting with perphenazine (trilafone): a double-blind study","volume":"19","author":"Moore","year":"1958","journal-title":"Anesthesiology"},{"key":"10.1002\/14651858.CD003443.pub2-BIB75|cit75","unstructured":"M\u00fcller M Pharmacokinetik\/Bioavailibility Evaluation of Three Different Perphenazine Formulations (Decentan) in 18 healthy volunteers E. Merck, Darmstadt 1994"},{"issue":"3","key":"10.1002\/14651858.CD003443.pub2-BIB76|cit76","first-page":"339","article-title":"Clinical experience with octoclothepin in psychoses. Comparasion with perphenazine","volume":"10","author":"Nahunek","year":"1968","journal-title":"Activitas Nervosa Superior"},{"issue":"5","key":"10.1002\/14651858.CD003443.pub2-BIB77|cit77","first-page":"281","article-title":"A comparison of therapeutic effects of triperidol and perphenazine in schizophrenia","volume":"65","author":"Nahunek","year":"1969","journal-title":"Ceskoslovenska Psychiatrie."},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB78|cit78","first-page":"56","article-title":"Comparison of triperidol with perphenazine in schizophrenic psychoses. Effect on the photomyoclonic threshold","volume":"12","author":"Nahunek","year":"1970","journal-title":"Activitas Nervosa Superior"},{"issue":"3","key":"10.1002\/14651858.CD003443.pub2-BIB79|cit79","first-page":"247","article-title":"Comparison of the therapeutic effect of flupenthixol and perphenazine in schizophrenia","volume":"12","author":"Nahunek","year":"1970","journal-title":"Activitas Nervosa Superior"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB80|cit80","first-page":"11","article-title":"Clinical experience with clozapin","volume":"71","author":"Nahunek","year":"1975","journal-title":"Ceskoslovenska Psychiatrie"},{"issue":"2","key":"10.1002\/14651858.CD003443.pub2-BIB81|cit81","first-page":"104","article-title":"Outline classification of neuroleptic drugs based on results of short-term control crossed studies in schizophrenia","volume":"72","author":"Nahunek","year":"1976","journal-title":"Ceskoslovenska Psychiatrie"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB82|cit82","first-page":"25","article-title":"On the question of differences between therapeutic responses after particular neuroleptics in comparison to perphenazine in schizophrenics","volume":"77","author":"Nahunek","year":"1981","journal-title":"Ceskoslovenska Psychiatrie"},{"issue":"3","key":"10.1002\/14651858.CD003443.pub2-BIB83|cit83","first-page":"154","article-title":"Controlled 'comparison' of perphenazine with perphenazine in schizophrenia - a methodical check of a double-blind cross-over design","volume":"22","author":"Nahunek","year":"1980","journal-title":"Activitas Nervosa Superior"},{"issue":"4","key":"10.1002\/14651858.CD003443.pub2-BIB84|cit84","first-page":"423","article-title":"Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicentre study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden","volume":"90","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD003443.pub2-BIB85|cit85","first-page":"952","article-title":"Perphenazine (Trilafon) in the treatment of pschoses","volume":"77","author":"O'Reilly","year":"1957","journal-title":"Canadian Medical Association Journal"},{"issue":"5","key":"10.1002\/14651858.CD003443.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1176\/ajp.123.5.607","article-title":"Perphenazine-amitriptyline in the treatment of schizophrenia","volume":"123","author":"Oltman","year":"1966","journal-title":"American Journal of Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD003443.pub2-BIB87|cit87","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0278-5846(89)90013-4","article-title":"The relationship between perphenazine plasma levels and clinical response in acute schizophrenia","volume":"13","author":"Omerov","year":"1989","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1176\/ajp.121.12.1147","article-title":"Time-series frequency analysis, and electrogenesis of the EEGs of normals and psychotics before and after drugs","volume":"122","author":"Pfeiffer","year":"1965","journal-title":"American Journal of Psychiatry."},{"issue":"5","key":"10.1002\/14651858.CD003443.pub2-BIB89|cit89","first-page":"317","article-title":"Intermittent pharmacotherapy in chronic schizophrenia","volume":"24","author":"Prien","year":"1973","journal-title":"Hospital and Community Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003443.pub2-BIB90|cit90","first-page":"80","article-title":"A controlled clinical trial of amitriptyline added to perphenazine in the treatment of depressed schizophrenics","volume":"15","author":"Prusoff","year":"1979","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD003443.pub2-BIB91|cit91","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0028-1094349","article-title":"Preliminary study of perphenazine enanthate in the treatment of chronic schizophrenia","volume":"5","author":"Rapp","year":"1972","journal-title":"Pharmakopsychiatrie Neuropsychopharmakologie"},{"issue":"5","key":"10.1002\/14651858.CD003443.pub2-BIB92|cit92","first-page":"665","article-title":"A double blind crossover study comparing haloperidol decanoate and perphenazine enanthate","volume":"39","author":"Rapp","year":"1986","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD003443.pub2-BIB93|cit93","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archpsyc.1967.01730250099014","article-title":"Competing voice messages. Effects of a message load and drugs on the ability of acute schizophrenics to attend","volume":"17","author":"Rappaport","year":"1967","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003443.pub2-BIB94|cit94","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00005053-196805000-00005","article-title":"Attention to competing voice messages by nonacute schizophrenic patients. Effects of message load, drugs, dosage levels and patient background","volume":"146","author":"Rappaport","year":"1968","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD003443.pub2-BIB96|cit95","unstructured":"Reznik I Sirota P Treatment of obsessive and compulsive symptoms in schizophrenia with SSRI's and neuroleptics: a randomized controlled trial 21st Congress of Collegium Internationale Neuro-psychopharmacologicum, Glasgow, Scotland, UK 1998"},{"issue":"4","key":"10.1002\/14651858.CD003443.pub2-BIB95|cit96","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00004714-200008000-00004","article-title":"Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics","volume":"20","author":"Reznik","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD003443.pub2-BIB97|cit97","first-page":"419","article-title":"Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study","volume":"43","author":"Rickels","year":"1982","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003443.pub2-BIB98|cit98","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00007611-197102000-00027","article-title":"Haloperidol for acute psychiatric emergencies. A double-blind comparison with perphenazine in acute alcoholic psychosis","volume":"64","author":"Ritter","year":"1971","journal-title":"Southern Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD003443.pub2-BIB99|cit99","first-page":"171","article-title":"Comparison of the therapeutic results of clothiapin and perphenazine in schizophrenia","volume":"13","author":"Rodova","year":"1971","journal-title":"Activitas Nervosa Superior"},{"issue":"2","key":"10.1002\/14651858.CD003443.pub2-BIB100|cit100","first-page":"94","article-title":"A blind comparison of clozapine and perphenazine in schizophrenics","volume":"15","author":"Rodova","year":"1973","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD003443.pub2-BIB101|cit101","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/bmj.1.5076.922","article-title":"Trials of perphenazine in the prevention of postoperative vomiting","volume":"1","author":"Scurr","year":"1958","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD003443.pub2-BIB102|cit102","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-0447.1993.tb03335.x","article-title":"Poor neuroleptic response in acutely exacerbated schizophrenic patients","volume":"87","author":"Shalev","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD003443.pub2-BIB103|cit103","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00004850-200015050-00002","article-title":"Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study","volume":"15","author":"Silver","year":"2000","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD003443.pub2-BIB104|cit104","series-title":"5th World Congress of Psychiatry, Ciudad de Mexico","first-page":"526","article-title":"Old wine in new bottles: decreased hostility in chronic psychotic inpatients treated with diphenylhydantoin (Dilantin)","author":"Simopoulos","year":"1971"},{"key":"10.1002\/14651858.CD003443.pub2-BIB105|cit105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0447.1970.tb02067.x","article-title":"A controlled trial of combined medications on behavioral and extrapyramidal effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD003443.pub2-BIB106|cit106","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1176\/ajp.116.5.392","article-title":"A graphic comparison of five phenothiazines","volume":"116","author":"Smith","year":"1959","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB107|cit107","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1176\/ajp.142.4.430","article-title":"The pharmacological treatment of delusional depression","volume":"142","author":"Spiker","year":"1985","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB108|cit108","first-page":"57","article-title":"Controlled comparative study of methylperidol and perphenazine in schizoprenic psychoses","volume":"12","author":"Svestka","year":"1970","journal-title":"Activitas Nervosa Superior"},{"issue":"2","key":"10.1002\/14651858.CD003443.pub2-BIB109|cit109","first-page":"93","article-title":"A comparison of pimozide with perphenazine in the treatment of acute schizophrenic episodes","volume":"14","author":"Svestka","year":"1972","journal-title":"Activitas Nervositas Superior"},{"issue":"2","key":"10.1002\/14651858.CD003443.pub2-BIB110|cit110","first-page":"103","article-title":"Comparison of the short-term therapeutic effect of oxyprothepine and perphenazine in schizophrenic patients. A controlled study","volume":"15","author":"Svestka","year":"1973","journal-title":"Activitas Nervosa Superior"},{"issue":"3","key":"10.1002\/14651858.CD003443.pub2-BIB111|cit111","first-page":"165","article-title":"A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses","volume":"16","author":"Svestka","year":"1974","journal-title":"Activitas Nervosa Superior"},{"issue":"3","key":"10.1002\/14651858.CD003443.pub2-BIB112|cit112","first-page":"208","article-title":"The position of trifluoperazine in the group of neuroleptics (a controlled clinical comparative study)","volume":"17","author":"Svestka","year":"1975","journal-title":"Activitas Nervosa Superior"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB113|cit113","first-page":"32","article-title":"Controlled cross over comparison of isofloxythepin and perphenazine in the treatment of schizophrenic psychoses","volume":"31","author":"Svestka","year":"1989","journal-title":"Activitas Nervosa Superior"},{"issue":"4","key":"10.1002\/14651858.CD003443.pub2-BIB114|cit114","first-page":"276","article-title":"Controlled cross over comparison of carbamazepine with perphenazine in schizophrenic psychoses. 31st Annual Psychopharmacology Meeting (1989, Jesenik, Czechoslovakia)","volume":"31","author":"Svestka","year":"1989","journal-title":"Activitas Nervosa Superior"},{"issue":"3","key":"10.1002\/14651858.CD003443.pub2-BIB115|cit115","first-page":"145","article-title":"Therapeutic results in schizophrenic and schizoaffective psychoses with sulpiride (Eglonyl Alkaloid), as compared with perphenazine (Perfenazin Spofa)","volume":"86","author":"Svestka","year":"1990","journal-title":"Ceskoslovenska Psychiatrie"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB116|cit116","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/030006059702500104","article-title":"Citalopram causes no significant alterations in plasma neuroleptic levels in schizophrenic patients","volume":"25","author":"Syvalahti","year":"1997","journal-title":"Journal of International Medical Research"},{"issue":"5","key":"10.1002\/14651858.CD003443.pub2-BIB117|cit117","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-0028-1094631","article-title":"A comparative study of the longacting neuroleptics perphenazine enanthate and flusipirilene","volume":"12","author":"Tegeler","year":"1979","journal-title":"Pharmakopsychiatrie Neuropsychopharmakologie"},{"issue":"3","key":"10.1002\/14651858.CD003443.pub2-BIB118|cit118","first-page":"351","article-title":"A double-blind controlled study on the usefulness of carpipramine-chlorpromazine combination in the pharmacotherapy of chronic schizophrenic patients","volume":"4","author":"Yagi","year":"1976","journal-title":"Rinsho Hyoka (Clinical Evaluation)"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB119|cit119","first-page":"1","article-title":"Current status of pharmacotherapy in schizophrenia","volume":"20","author":"Akimoto","year":"1966","journal-title":"Folia Psychiatrica et Neurologica Japonica"},{"key":"10.1002\/14651858.CD003443.pub2-BIB120|cit120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1176\/ajp.117.2.97","article-title":"Treatment of schizophrenic reactions with phenothiazine derivates. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine and phenobarbital","volume":"117","author":"Casey","year":"1960","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003443.pub2-BIB121|cit121","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/08039487609097207","article-title":"A double-blind comparison study between penfluridol and perphenazine in acute schizophrenic patients","volume":"30","author":"Eklund","year":"1976","journal-title":"Nordisk Psykiatrisk Tidsskrift"},{"key":"10.1002\/14651858.CD003443.pub2-BIB122|cit122","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1176\/ajp.117.10.930","article-title":"Thresholds for drug-induced akathisia","volume":"117","author":"Freedman","year":"1961","journal-title":"Journal of American Psychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB123|cit123","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/ajp.115.7.577","article-title":"Therapeutic implications of differential effects of new phenothiazine compounds","volume":"116","author":"Freyhan","year":"1959","journal-title":"American Journal of Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD003443.pub2-BIB124|cit124","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/070674378803300906","article-title":"Relationship of adverse drug reactions to length of hospital-stay in genetically subgrouped schizophrenics","volume":"33","author":"Galdi","year":"1988","journal-title":"Canadian Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003443.pub2-BIB125|cit125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0033-3182(69)71755-8","article-title":"The differential prediction of response to two anti-psychotic drugs","volume":"10","author":"Goldstein","year":"1969","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1002\/14651858.CD003443.pub2-BIB126|cit126","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cpt196782249","article-title":"Specific therapeutic actions of acetophenazine, perphenazine, and benzquinamide in newly admitted schizophrenic patients","volume":"8","author":"Hollister","year":"1967","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD003443.pub2-BIB127|cit127","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1600-0447.1971.tb02203.x","article-title":"A double-blind controlled trial of thiothixene and perphenazine in chronic schizophrenics shown to require maintenance therapy","volume":"47","author":"Kellam","year":"1971","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB128|cit128","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0920-9964(00)90763-1","article-title":"Olanzapine and perphenazine in schizophrenia","volume":"41","author":"Naukkarinen","year":"2000","journal-title":"Schizophrenia Research"},{"issue":"25","key":"10.1002\/14651858.CD003443.pub2-BIB129|cit129","first-page":"1682","article-title":"The effects of neuroleptics on tardive dyskinesias. A video-controlled, randomized study of chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden","volume":"149","author":"Povlsen","year":"1987","journal-title":"Ugeskrift for Laeger"},{"issue":"12","key":"10.1002\/14651858.CD003443.pub2-BIB130|cit130","first-page":"366","article-title":"Trilafon (perphenazine) and largactil (chlorpromazine) in chronic schizophrenia. A comparison","volume":"120","author":"Schulsinger","year":"1958","journal-title":"Ugeskrift for Laeger"},{"key":"10.1002\/14651858.CD003443.pub2-BIB131|cit131","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0924-977X(99)80301-0","article-title":"Subjective experiences of schizophrenic patients on atypical antipsychotic olanzapine and typical antipsychotic perphenazine","volume":"9","author":"Szafranski","year":"1999","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003443.pub2-BIB132|cit132","first-page":"315","article-title":"Differences in therapeutic effects of phenothiazine drugs","volume":"9","author":"Vinar","year":"1968","journal-title":"Agressolgie"},{"key":"10.1002\/14651858.CD003443.pub2-BIB133|cit133","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003443.pub2-BIB134|cit134","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials. The CONSORT statement [comment]","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003443.pub2-BIB135|cit135","volume-title":"Psychiatrische Pharmakotherapie","author":"Benkert","year":"1996"},{"key":"10.1002\/14651858.CD003443.pub2-BIB136|cit136","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Trials in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003443.pub2-BIB137|cit137","unstructured":"Bundesverband der Pharmazeutischen Industrie (editors) No English title given Fachinformation Decentan 2001 1 4"},{"issue":"1","key":"10.1002\/14651858.CD003443.pub2-BIB138|cit138","article-title":"Cochrane Reviewers' Handbook","author":"Clarke","year":"2000","journal-title":"The Cochrane Library [database on disk and CDROM]"},{"key":"10.1002\/14651858.CD003443.pub2-BIB139|cit139","series-title":"Abstracts of the 8th International Cochrane Colloquium","article-title":"Issues in the selection for meta-analyses of binary data","author":"Deeks"},{"key":"10.1002\/14651858.CD003443.pub2-BIB140|cit140","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis errror in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD003443.pub2-BIB141|cit141","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003443.pub2-BIB142|cit142","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD003443.pub2-BIB143|cit143","first-page":"124","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD003443.pub2-BIB144|cit144","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003443.pub2-BIB145|cit145","first-page":"1","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume-title":"Controlled clinical trials","volume":"17","author":"Jadad","year":"1996"},{"key":"10.1002\/14651858.CD003443.pub2-BIB146|cit146","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD003443.pub2-BIB147|cit147","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003443.pub2-BIB148|cit148","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomised trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003443.pub2-BIB149|cit149","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD003443.pub2-BIB150|cit150","volume-title":"Martindale. The complete drug reference","author":"Parfitt","year":"1999"},{"issue":"5","key":"10.1002\/14651858.CD003443.pub2-BIB151|cit151","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003443.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T00:00:00Z","timestamp":1425600000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003443.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T17:45:31Z","timestamp":1705772731000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003443.pub2"}},"subtitle":[],"editor":[{"given":"Benno","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,1,24]]},"references-count":151,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003443.pub2","relation":{},"subject":[],"published":{"date-parts":[[2005,1,24]]}}}